Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
, 51 (8), 858-62

Coccidioidomycosis in Infants: A Retrospective Case Series

Observational Study

Coccidioidomycosis in Infants: A Retrospective Case Series

Jessica M Lee et al. Pediatr Pulmonol.


Introduction: In contrast to adults, coccidioidomycosis is a rare disease in infants and the mechanisms of disease acquisition are not well described in infants. The purpose of this study was to describe the clinical presentation, treatment, and outcome of pulmonary coccidioidomycosis in infants in an endemic area.

Methods: We performed a retrospective observational study of all patients less than 12 months of age admitted to a tertiary free standing children's hospital from 2003-2012 diagnosed with coccidioidomycosis.

Results: Thirteen infants were hospitalized during the study period. The majority of the patients presented with upper and/or lower respiratory tract infection. The most common presenting symptoms included fever (77%), cough (61%), and respiratory distress (38%). Disseminated disease, included pericardial effusion, neck abscess, and lesions in the cerebellum, basal ganglia and left temporoparietal skull. Fluconazole was the initial, antifungal agent used. Amphotericin B was reserved for significant lung disease and disseminated cases. Failed response to fluconazole and amphotericin B were treated with a combination of voriconazole and caspofungin. Average length of treatment was 4 years. All patients survived to hospital discharge. The majority of the patients had resolution of chest radiograph and coccidiodal complement fixing antibody titers.

Discussion: Infant coccidioidomycosis has a non-specific presentation and can mimic common infant respiratory illnesses. In endemic areas, coccidioidomycosis should be considered in the differential diagnosis of infants with pulmonary symptoms unresponsive to conventional treatment. Pediatr Pulmonol. 2016;51:858-862. © 2016 Wiley Periodicals, Inc.

Keywords: coccidioidomycosis; infants; infections: pneumonia.

Similar articles

  • Primary Pulmonary Coccidioidomycosis in China
    F Lan et al. Respirology 15 (4), 722-5. PMID 20409030.
    Coccidioidomycosis is a fungal infection endemic to south-west USA, north Mexico and parts of Central and South America. We report here a case of primary pulmonary coccid …
  • Miliary Coccidioidomycosis in the Immunocompetent
    EL Arsura et al. Chest 117 (2), 404-9. PMID 10669682.
    We present eight immunocompetent patients with a lower mortality rate and better outcome than previously reported. In our series, miliary coccidioidomycosis manifested as …
  • Combination Therapy of Disseminated Coccidioidomycosis With Caspofungin and Fluconazole
    DW Park et al. BMC Infect Dis 6, 26. PMID 16480497. - Case Reports
    This appears to be the first case of diffuse coccidioidal pneumonia with skin involvement in an immunocompetent patient who was treated successfully with caspofungin and …
  • Treatment Considerations in Pulmonary Coccidioidomycosis
    CA Hartmann et al. Expert Rev Respir Med 10 (10), 1079-91. PMID 27635942. - Review
    This review discusses current literature regarding medical treatment options, including the various triazoles and amphotericin B products. In addition, we discuss uncompl …
  • Pulmonary Coccidioidomycosis
    GR Thompson 3rd. Semin Respir Crit Care Med 32 (6), 754-63. PMID 22167403. - Review
    Coccidioidomycosis refers to the spectrum of disease caused by the dimorphic fungi Coccidioides immitis and Coccidioides posadasii. Clinical manifestations vary depending …
See all similar articles

Publication types

MeSH terms